4.2 Article

Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA

Journal

CANCER INVESTIGATION
Volume 36, Issue 2, Pages 118-128

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2018.1430816

Keywords

Antibodies; radiolabeling; PSMA; prostate cancer

Categories

Ask authors/readers for more resources

Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can carry the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available